Growth Metrics

Gilead Sciences (GILD) Gross Profit (2016 - 2025)

Gilead Sciences (GILD) has disclosed Gross Profit for 17 consecutive years, with $6.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit rose 5.23% year-over-year to $6.3 billion, compared with a TTM value of $23.2 billion through Dec 2025, up 3.14%, and an annual FY2025 reading of $23.2 billion, up 3.14% over the prior year.
  • Gross Profit was $6.3 billion for Q4 2025 at Gilead Sciences, up from $6.2 billion in the prior quarter.
  • Across five years, Gross Profit topped out at $6.3 billion in Q4 2025 and bottomed at $4.6 billion in Q4 2021.
  • Average Gross Profit over 5 years is $5.4 billion, with a median of $5.3 billion recorded in 2022.
  • The sharpest move saw Gross Profit dropped 23.34% in 2021, then increased 29.8% in 2022.
  • Year by year, Gross Profit stood at $4.6 billion in 2021, then grew by 29.8% to $6.0 billion in 2022, then dropped by 16.17% to $5.0 billion in 2023, then increased by 19.19% to $6.0 billion in 2024, then increased by 5.23% to $6.3 billion in 2025.
  • Business Quant data shows Gross Profit for GILD at $6.3 billion in Q4 2025, $6.2 billion in Q3 2025, and $5.6 billion in Q2 2025.